【レポートの概要（一部）】
1. Report Overview
1.1 The Indian Pharmaceutical Market Overview
1.2 Indian Pharmaceutical Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
1.10 About Visiongain
2. Indian Healthcare: Overview
2.1 India: Demographic Indicators Overview
2.2 Indian Healthcare system: Overview
2.2.1 Rashtriya Swasthya Bima Yojana – Bringing Healthcare Coverage to India’s Poorest Workers
2.3 Analysis of India’s Healthcare Expenditure
2.4 State Bodies regulating the Indian Pharmaceutical Market
2.4.1 The Drugs and Cosmetics Act, 1940
3. Indian Pharmaceutical Market: Discussions and Predictions 2016-2026
3.1 Indian Pharmaceutical Market: The Third Biggest Market in the World by Volume, 2015
3.2 Indian Pharmaceutical Market: Overall Revenue Forecast 2016-2026
4. Medical Treatment Needs in India, 2016-2026
4.1 Disease Prevalence in India, 2016-2026
4.2 Disease Incidence in India, 2016-2026
4.3 Disease Mortality Rates in India, 2016-2026
4.3.1 Top Causes of Death in India
4.3.2 Top Causes of Death in India: Mortality Projections, 2016-2026
5. Indian Pharmaceutical Market: Leading Therapeutic Areas, 2016-2026
5.1 Leading Therapeutic Areas in the Indian Pharmaceutical Market: Overview, 2015
5.2 Indian Pharmaceutical Market: Leading Therapeutic Areas Forecasts, 2016-2026
5.3 Infectious Disease Therapeutics: Overview, 2015
5.3.1 Infectious Disease Drugs Market: Forecast, 2016-2026
5.3.2 Diarrheal Diseases Responsible for Over Half a Million Annual Deaths, 2015
5.3.3 Lower Respiratory Tract Infections Among Leading Causes of Death in 2015
5.3.4 Tuberculosis Still Rife in India
5.3.5 Malaria, Risk and Opportunity
5.3.6 HIV in India: Growing Therapeutic Area Worth Watching
5.3.7 Drivers and Restraints for the Infectious Diseases Pharmaceutical Segment, 2015-2026
5.4 Cardiovascular Therapeutic Segment: Overview, 2015
5.4.1 Cardiovascular Disease – India’s Leading Cause of Death, 2015
5.4.2 Cardiovascular Drugs Market: Forecast, 2016-2026
5.4.3 Drivers and Restraints for the Indian Cardiovascular Drugs Market, 2015-2026
5.5 Gastro-Intestinal Therapeutic Segment: Overview, 2015
5.5.1 Gastro-Intestinal Drugs Market: Forecast, 2016-2026
5.5.2 Gastro-Intestinal Drugs in India: Challenges and Opportunities
5.5.3 Drivers and Restraints for the Gastro-Intestinal Drugs Segment, 2015
5.6 Respiratory Therapeutic Segment: Overview, 2015
5.6.1 Respiratory Disease Drugs Market: Forecast, 2016-2026
5.6.2 Drivers and Restraints for the Respiratory Diseases Segment, 2015
5.7 Pain Relief / Analgesics Therapeutic Segment: Overview, 2015
5.7.1 Pain Relief / Analgesics Drugs Market: Forecast, 2016-2026
5.7.2Drivers and Restraints for the Pain Relief / Analgesics Drugs Segment, 2015
5.8 Diabetes Therapeutic Segment: Overview, 2015
5.8.1 Diabetes Drugs Market: Forecast, 2016-2026
5.8.2 Drivers and Restraints for the Diabetes Drugs Segment, 2015
5.9 Vitamins / Minerals / Nutrients Therapeutic Segment: Overview, 2015
5.9.1 Vitamins / Minerals / Nutrients Drugs Market: Forecast, 2016-2026
5.9.2 Vitamins / Minerals / Nutrients in India: Challenges and Opportunities
5.9.3 Drivers and Restraints for the Vitamins / Minerals / Nutrients Drugs Segment, 2015
5.10 Dermatological Therapeutic Segment: Overview, 2015
5.10.1 Dermatological Drugs Market: Forecast, 2016-2026
5.10.2 Drivers and Restraints for the Dermatological Drugs Segment, 2015
5.11 Central Nervous System (CNS) Therapeutics: Overview, 2015
5.11.1 CNS Drugs Market: Forecast, 2016-2026
5.11.2 Intentional Injury Among the Top 10 Leading Causes of Death, 2015:
5.11.3 India’s Aging Population: Driver for the CNS Segment
5.11.4 Drivers and Restraints for the CNS Drugs Segment, 2015
5.12 Gynaecological Treatment Market Overview: 2015
5.12.1 Infant Mortality Still High in India
5.12.2 Indian Gynaecological Treatments Market: Forecast, 2016-2026
5.12.3 Drivers and Restraints for the Gynaecological Segment, 2015
5.13 Other Pharmaceutical Products Market Overview: 2015
5.13.1 Incidence of Cancer in India is Rising
5.13.2 Indian Other Treatments Market: Forecast, 2016-2026
6. Indian Pharmaceutical Market: Leading Drug Types, 2016-2026
6.1 Drug Types in the Indian Market: Overview, 2015
6.2 Growth Forecasts for Leading Drug Types in India, 2016-2026
6.3 Generic Drugs Dominate the Indian Pharmaceutical Market
6.3.1 Indian Generics: Overview, 2015
6.3.2 Indian Generic Drugs Market: Forecast, 2016-2026
6.3.3 Branded Generics Preferred by Many Indian Patients
6.3.4 Drivers and Restraints for the Generic Drug Market in India, 2015
6.4 Indian Over-The-Counter (OTC) Drugs Market: Overview, 2015
6.4.1 Indian OTC Market: Forecast, 2016-2026
6.4.2 Drivers and Restraints of the Indian OTC Market
6.5 Indian Patented Drugs Market: Overview, 2015
6.5.1 Indian Patented Drugs Market: Forecasts, 2016-2026
6.5.2 Drivers and Restraints for the Indian Patented Drugs Market
6.6 Indian Biosimilar Drugs, 2015
6.6.1 Indian Biosimilar Drugs Market: Forecast, 2016-2026
6.6.2 A Number of Blockbuster Drugs Coming Off-Patent Over the Next Decade
6.6.3 Drivers and Restraints of the Indian Biosimilar Drugs Market
7. The Leading Companies in the Indian Pharmaceutical Market, 2016-2026
7.1 Indian Pharmaceutical Market Overview
7.1.1 Indian Pharmaceutical Patent Law and the Effect on Big Pharmaceutical Companies
7.2 Top 50 Domestic Indian Pharmaceutical Companies, 2015
7.3 Sun Pharmaceuticals Industries Limited
7.3.1 Sun Pharma: Global Presence
7.3.1.1 Sun Pharmaceutical Sales by Region, 2015
7.3.2 Sun Pharmaceuticals Business Performance 2006-2015
7.3.3 Sun Pharmaceutical: Ranbaxy Laboratories Acquisition is the Largest Ever Deal Made by an Indian Pharmaceutical Company
7.3.3.1 Other Major M&A Activity
7.4 Abbott Healthcare Private Limited (Abbott India)
7.4.1 Abbott India: Business Performance 2006-2015
7.4.2 Abbott India: Key Brands in the Indian Pharmaceutical Market
7.4.3 Abbott India: Major and Recent M&A Activity
7.5 Cipla Ltd.
7.5.1 Cipla: Business Performance 2006-2015
7.6 Cadila Healthcare Limited
7.6.1 Cadila: Business Performance 2006-2015
7.6.2 Cadila Healthcare Revenue by Therapeutic Area 2015
7.6.3 Cadila Healthcare Revenue by Business Area 2015
7.7 GlaxoSmithKline Pharmaceuticals Limited
7.7.1 GlaxoSmithKline India: Business Performance 2006-2015
7.7.2 GlaxoSmithKline India: Revenue by Product Type, 2015
7.8 Pfizer Limited. India
7.8.1 Pfizer India: Business Performance 2006-2015
7.7.2 Pfizer India: Revenue by Product Type, 2015
7.9 Lupin
7.9.1 Lupin: Business Performance 2006-2015
7.9.2 Lupin Revenue by Therapeutic Area, 2015
8. Qualitative Analysis of the Indian Pharmaceutical Market, 2015
8.1 Indian Pharmaceutical Market: Drivers and Restraints
8.2 SWOT Analysis of the Indian Pharmaceutical Market, 2015-2026
8.3 Strengths
8.3.1 Increasing Investment in the Healthcare System
8.3.2 The Disease Burden and GDP Both Growing
8.3.3 India’s Population Set to Become the World’s Largest by 2030
8.3.4 India Popular for Pharmaceutical Outsourcing
8.4 Weaknesses
8.4.1 Stringent Pricing Regulations Hit the Indian Pharmaceutical Market
8.4.2 Poor Infrastructure Threatens to Hinder Market Potential
8.4.3 Intense Competition Driving Down Drug Prices
8.5 Opportunities
8.5.1 Global Demand for Generics Rising
8.5.2 National Rural Health Mission Driving Healthcare Access in Rural Areas
8.5.3 Significant Investment from MNCs Expected
8.5.4 Innovative Biotechnology Sector Set to Capitalise on Patent Expiries
8.6 Threats
8.6.1 Rise of Other Low-Cost Generic Exporters
8.6.2 Will the Indian Government Stick to Increasing Healthcare Expenditure?
8.6.3 Recent Warnings and Export Bans from Regulatory Bodies Hit Confidence in Indian Pharmaceuticals
8.7 Porter’s Five Forces Analysis of the Indian Pharmaceutical Market
8.7.1 Rivalry Among Competitors [High]
8.7.2 Threat of New Entrants [Low]
8.7.3 Power of Suppliers [Medium]
8.7.4 Power of Buyers [High]
8.7.5 Threat of Substitutes [Low]
9. Conclusion
9.1 The Indian Pharmaceutical Market: Growing Global Market Share
9.2 Indian Pharmaceutical Market: Chronic Diseases Becoming Increasingly Prevalent
9.3 Commercial Drivers of the Indian Pharmaceutical Market
9.4 Commercial Restraints of the Indian Pharmaceutical Market
9.5 Concluding Remarks
10. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
【レポート販売概要】
■ タイトル：インドの医薬品市場：ジェネリック医薬品、OTC医薬品、特許薬、バイオシミラー■ 英文：Indian Pharmaceutical Market Forecast 2016-2026
■ 発行日：2015年12月
■ 調査会社：visiongain
■ 商品コード：VGAIN5122116
■ 調査対象地域：インド
- 電子・電気産業における産業用ロボットの世界市場About Industrial Robotics Industrial robotics can be defined as the use of robots in the manufacturing processes of industries such as electronic and electrical, food and beverage, and automotive. Industrial robots are programmed to control and automate manufacturing processes in industries. They are classified according to various technical parameters such as number of axes, degrees of freedom, w …
- 大型車用オイルの世界市場2015-2019About heavy duty motor oil HDMO refers to motor oils for diesel engines used in highway vehicles and in mining and agricultural equipment. HDMO reduces friction and wear and tear of the moving engine's crankshaft, connecting rods, bearings, and pistons. It also serves as an effective coolant while inhibiting the formation of deposits and preventing rust and corrosion. The market figures in the rep …
- グローバル防衛市場の景況感レポート（2014年Q2）Summary “Defense Business Confidence Report Q2 2014” is a new report by Strategic Defence Intelligence that globally analyzes industry opinions on the latest economic and customer issues, and their impact on investment decisions and growth prospects within the defense industry. This report also examines executive opinion about the current and future state of the economy and its retrospective effec …
- 食道疾患(Esophageal Diseases)：世界の治験レビュー（2015年上半期版）Esophageal Diseases Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Esophageal Diseases Global Clinical Trials Review, H1, 2015" provides data on the Esophageal Diseases clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Esophageal Diseases. It includes an overview of the trial numbers and their recru …
- 起立性低血圧症治療薬の世界市場2019-2023Global Orthostatic Hypotension Drugs Market 2019-2023: About the Market Orthostatic hypotension is the reduction in systolic blood pressure and can be divided into neurogenic and non-neurogenic forms. Technavio’s orthostatic hypotension drugs market analysis considers sale from midodrine, northera (droxidopa), fludrocortisone, and other drugs. Our analysis also considers the orthostatic hypotensio …
- EnCana Corporation社の石油・ガス開発・生産動向及びコスト分析（2013年第4四半期）EnCana Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2013 Summary EnCana Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for k …
- Endotoxemia：グローバル臨床試験レビューH1, 2013Endotoxemia Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Endotoxemia Global Clinical Trials Review, H1, 2013" provides data on the Endotoxemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Endotoxemia. It includes an overview of the trial numbers and their recruitment status as per the site of …
- 眼科用超音波装置の世界市場2019-2023About this market Increasing business strategies to drive market growth. Companies develop business strategies to increase their products. strengthen their market position. and expand their offices for direct and indirect sales. Such business strategies help them to increase their sales. which boosts market growth. Technavio’s analysts have predicted that the ophthalmic ultrasound devices market w …
- Ithaca Energy Inc.：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Ithaca Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Ithaca Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for k …
- 世界の自動車用OE(メーカー純正部品)照明（ライト）市場（2008-2028）This latest just-auto report edition offers a global review of the OE lighting sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE lighting market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players including their strategies and prospects Mar …
- 柔軟剤の世界市場2017-2021About Fabric Conditioner Fabric conditioner is a constituent added to clothes during the washing process to make them softer and more durable. The chemicals in these products also remove stains and prevent the fabric from developing static electricity, extending the life of the garment. A fabric conditioner functions by depositing a lubricating chemical on the fabric, which imparts it softness, re …
- スパイス（香辛料）及びスティミュラント（コーヒー、ココア、茶）の世界市場About Spices and Stimulants Spices and stimulants are plant products. Spices constitute a large variety of phytonutrients and antioxidants. Primarily used for their palatability, flavor, and aroma (derived from phytochemicals), spices find extensive usage in the culinary industry. Stimulants offer increased vigor temporarily and contain chemicals such as caffeine, l-theanine, theophylline, and the …
- International Frontier Resources Corporation：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013International Frontier Resources Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary International Frontier Resources Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of …
- 水性塗料の世界市場：樹脂別（アクリル、ポリウレタン、エポキシ、アルキド、ポリエステル、PTFE、PVDC、PVDF、その他）、用途別、地域別、セグメント予測The global waterborne coatings market is projected to reach USD 82.9 billion by 2025, according to a new report by Grand View Research, Inc. The market is projected to expand at CAGR of 5.7% over the forecast period. The prices of raw materials used in manufacturing waterborne coatings are expected to have a significant impact on the production cost of the final product. The demand for these raw m …
- エナジードリンクの世界市場：種類別（アルコール、非アルコール）、エンドユーザー別（子供、大人、青少年）The global energy drinks market size was valued at $53.01 billion in 2018, and is expected to grow at a CAGR of 7.20% to reach $86.01 billion by 2026. Energy drinks are beverages that contain caffeine, taurine, vitamins, and other stimulants, and are marketed as products that boost mental alertness and physical stamina. These drinks may or may not be carbonated. They differ from sports drink, whic …
